Niki BioSolutions, Inc. Shareholders' Equity
Niki BioSolutions, Inc. (NIKI) had Shareholders' Equity of $23.12 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-11
- 2025-12-31: Stockholders' Equity Attributable to Parent $23.12M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $22.53M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $23.13M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $21.13M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $23.12M S-4/A · filed 2026-05-11 |
| 2025-09-30 | $22.53M 6-K · filed 2026-01-22 |
| 2025-06-30 | $23.13M 6-K · filed 2025-10-08 |
| 2024-12-31 | $21.13M S-4/A · filed 2026-05-11 |
| 2024-06-30 | $22.65M 6-K · filed 2024-12-20 |
| 2023-12-31 | $24.85M 6-K · filed 2025-10-08 |
| 2023-06-30 | $21.84M 6-K · filed 2023-12-22 |
| 2022-12-31 | $15.71M 20-F · filed 2024-04-30 |
| 2022-06-30 | $22.65M 6-K · filed 2022-09-30 |
| 2021-12-31 | $23.61M 20-F · filed 2023-04-28 |
| 2021-06-30 | $31.51M 6-K · filed 2021-09-15 |
| 2020-12-31 | $41.83M 20-F/A · filed 2023-01-17 |
| 2020-06-30 | $19.84M 6-K · filed 2020-09-02 |
| 2019-12-31 | $16.36M 20-F · filed 2021-04-19 |
| 2018-12-31 | $33.11M 20-F · filed 2020-04-29 |
| 2017-12-31 | $30.24M 20-F · filed 2019-04-15 |